Current Issue
VOL 15 NO 1 • Jan/Feb 2024
This issue’s cover illustration depicts pineoblastoma in a young boy. A pineoblastoma is a high-grade, fast-growing tumor of the pineal region of the brain. It usually occurs in children and young people between the ages of 20 and 40 years. Artwork by Alexandra Webber © 2024, DNA Illustrations, Inc., Asheville, North Carolina.EditorialBeth Faiman, PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, FAPOIt is known among clinicians, including advanced practitioners (APs), that non-medical factors will influence health outcomes and contribute to health disparities. Factors such as socioeconomic position, access to health-care and education systems, and living conditions impact whether a patient w...
Research and ScholarshipTina Harris,(1) DNP, NP-C, AOCNP®, Julie Brinzo,(1) DNP, APRN, MBA, FNP-C, and Christopher Pell,(2) PhDCancer patients continually face the consequences of adverse effects related to their cancer treatment, especially when it concerns the burden of financial toxicity (FT). Financial toxicity describes the objective financial burden and subjective financial distress experienced by cancer patients d...
Research and ScholarshipJennifer L. Raybin,(1) PhD, RN, CPNP, Andrew Donson,(1) Nicholas K. Foreman,(1) MRCP, Rajeev Vibhakar,(1) MD, Michael H. Handler,(1) MD, and Arthur K. Liu,(2) MD, PhDAdvanced practitioners (APs) are integral clinicians in the care of patients experiencing adverse effects of cancer treatments. They are also on the front lines in the daily discussions of prognosis between patients and interdisciplinary oncology teams. An opportunity exists for APs to improve bo...
Review ArticleMaggie Matyola, APRN, FNP-C, Ashley Martinez, DNP, APRN, FNP-BC, Joyce Dains, DrPH, JD, APRN, FNP-BC, FNAP, FAANP, FAAN The method of treatment delivery in cancer patients is frequently evaluated to determine the maximum efficacy of selected treatments. In delivering anticancer therapy for solid tumor malignancies, challenges are often encountered when evaluating drug penetrance and systemic adverse effects (Maeda...
Grand RoundsJared Thorley,(1) APRN, MSN, FNP, and Saneese Stephen,(2) MPAS, PA-C, MPACase Study 1: Advanced Localized Disease
These patient cases are fictional and do not represent events or a response from an actual patient. The authors developed these fictional cases for educational purposes only.
Diagnosis
Fred is a 70-year-old man with a history of localized prostate cancer, ...
Practice MattersAnna Poullard, DNP, MSN, APRN-BC, and Sheena Charles, MS, FNP-BC The primary objectives of early phase clinical trials are to determine the safety and tolerability of investigational agents and to determine the recommended doses for patients with advanced cancer (Sikic et al., 2019). The advances made in the treatment of cancer have contributed to patients wit...
Diagnostic SnapshotCatherine Joseph, MSN, APN, AGACNP-BCOncology History
Ms. S is a 52-year-old woman with refractory stage IIB classical Hodgkin lymphoma first diagnosed in 2015. A month before diagnosis, she sought treatment from her primary care physician for swelling on the right side of her neck, drenching night sweats, and episodes of unexplaine...
Meeting AbstractJL1101C: A Financial Toxicity Screening and Care Coordination Quality Improvement Program in a Gynecology Oncology Urban Practice
Tina Q. Harris,1 DNP, NP-C, AOCNP, and Julie A. Brinzo,2 DNP, APRN, MBA, FNP-C; 1Chattanooga Cancer Support Services, 2University of North Georgia
Background: There ar...